A New Neurotech Startup Launches to Rival Sam Altman’s Merge Labs

Bridge Neurotech’s launch signals intensifying competition in brain-computer interfaces and a possible shift from highly invasive implants toward wearable, noninvasive systems that could eventually reach far larger markets. For CIOs and technology leaders, the strategic takeaway is that ultrasound plus predictive AI could open new medical and consumer use cases, but the approach still faces major hurdles in signal latency, clinical validation, and real-world performance before it becomes enterprise-relevant.